Trial ID or NCT#

NCT04552769

Status

not recruiting iconNOT RECRUITING

Purpose

The purpose of the study is to evaluate the efficacy of treatment with abemaciclib in patients with anaplastic thyroid/undifferentiated thyroid

Official Title

Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Saad A. Khan, MD
Saad A. Khan, MD
Medical oncologist
Assistant Professor of Medicine (Oncology)

Contact us to find out if this trial is right for you.

CONTACT

Michelle D Jun
(650) 721-4079